Funding to support establishment of the world´s first fully automated production facility for resorbable medical scaffolds based in Australia AI-driven, no-touch manufacturing to ensure highest quality, safety and sterility levels Designed to manufacture up to 100,000 scaffolds per annum at full capacity Leipzig, Germany, and Queensland, Australia. June 5, 2024 – BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable scaffolds using additive manufacturing technologies, announced today that its Australian subsidiary has received financial assistance through the Queensland Government's Industry Partnership Program. The proceeds will be used to establish the world´s first fully automated, TGA/ISO 13485-certified manufacturing facility for 3D-printed medical implants. The new facility will be designed to manufacture BellaSeno´s innovative, resorbable breast and bone scaffolds in Australia. The facility will be established at the Herston Health Precinct with assistance from Metro North Health, the largest of the 16 Hospital and Health Services (HHS) that provide public health services in Queensland. "We are delighted to have received non-dilutive financial support for our Australian activities," said ...